Antimicrobial resistance in bacterial isolates from companion animals in Buenos Aires, Argentina: 2011-2017 retrospective study.
The widespread use of antimicrobial therapy in companion animals could lead to increased levels of resistance. Monitoring these levels is critical to understand not only the zoonotic threat of resistant bacteria but also the interspecies transmission of resistance mechanisms. However, data on resistance levels in companion animals of urban areas in Latin America are lacking. In this retrospective study, we analysed 23,922 isolates recovered from clinical samples of dogs and cats between 2011 and 2017. Growing trends of resistance to fluoroquinolones were observed in most bacterial species of veterinary importance with zoonotic potential (Enterobacterales, Pseudomonas and Staphylococcus). Furthermore, an increase of resistance levels to third-generation cephalosporins was also detected in Enterobacterales. Currently, Pseudomonas aeruginosa, Enterococcus spp. and Streptococcus spp. did not seem to represent a clinical challenge. A high proportion of multidrug-resistant (MDR) Enterobacterales isolated from urine was reported. It is interesting to outline that resistance to amikacin was exceptional. This study might be considered as a baseline for prospective antimicrobial resistance surveillance in companion animals in our region.
['Rumi|María Valeria|MV|', 'Nuske|Ezequiel|E|', 'Mas|Javier|J|', 'Argüello|Andrea|A|', 'Gutkind|Gabriel|G|', 'Di Conza|José|J|0000-0003-0520-1744']
D000818:Animals D000900:Anti-Bacterial Agents D001118:Argentina D001419:Bacteria D001424:Bacterial Infections D024901:Drug Resistance, Multiple, Bacterial D006801:Humans D057805:Pets
antimicrobial resistance dogs cats trends Enterobacterales Pseudomonas Staphylococcus Enterococcus Streptococcus multidrug-resistant E. coli